- Home
- FEMY vs EDUC Comparison
FEMY vs EDUC Comparison
Compare FEMY & EDUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEMY
- EDUC
- Stock Information
- Founded
- FEMY 2004
- EDUC 1965
- Country
- FEMY United States
- EDUC United States
- Employees
- FEMY N/A
- EDUC N/A
- Industry
- FEMY Medical/Dental Instruments
- EDUC Consumer Specialties
- Sector
- FEMY Health Care
- EDUC Consumer Discretionary
- Exchange
- FEMY Nasdaq
- EDUC Nasdaq
- Market Cap
- FEMY 12.5M
- EDUC 11.7M
- IPO Year
- FEMY 2021
- EDUC N/A
- Fundamental
- Price
- FEMY $0.60
- EDUC $1.53
- Analyst Decision
- FEMY Strong Buy
- EDUC
- Analyst Count
- FEMY 3
- EDUC 0
- Target Price
- FEMY $7.33
- EDUC N/A
- AVG Volume (30 Days)
- FEMY 6.9M
- EDUC 720.6K
- Earning Date
- FEMY 11-11-2025
- EDUC 10-09-2025
- Dividend Yield
- FEMY N/A
- EDUC N/A
- EPS Growth
- FEMY N/A
- EDUC N/A
- EPS
- FEMY N/A
- EDUC N/A
- Revenue
- FEMY $1,887,016.00
- EDUC $31,304,000.00
- Revenue This Year
- FEMY $103.55
- EDUC N/A
- Revenue Next Year
- FEMY $148.13
- EDUC N/A
- P/E Ratio
- FEMY N/A
- EDUC N/A
- Revenue Growth
- FEMY 98.61
- EDUC N/A
- 52 Week Low
- FEMY $0.31
- EDUC $0.92
- 52 Week High
- FEMY $1.80
- EDUC $2.25
- Technical
- Relative Strength Index (RSI)
- FEMY 59.98
- EDUC 61.69
- Support Level
- FEMY $0.34
- EDUC $1.25
- Resistance Level
- FEMY $0.92
- EDUC $1.65
- Average True Range (ATR)
- FEMY 0.06
- EDUC 0.10
- MACD
- FEMY 0.05
- EDUC 0.01
- Stochastic Oscillator
- FEMY 50.50
- EDUC 77.50
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
About EDUC Educational Development Corporation
Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.